The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global AI Drug Development Platform Market Research Report 2024
Synopsis
Global AI Drug Development Platform market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole AI Drug Development Platform market research.
Key companies engaged in the AI Drug Development Platform industry include Insilico Medicine, MindRank, BenevolentAI, Exscientia, Deep Pharma Intelligence, Delta4, DNDi, Standigm and Genesis Therapeutics, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of AI Drug Development Platform were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole AI Drug Development Platform market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global AI Drug Development Platform market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Insilico Medicine
MindRank
BenevolentAI
Exscientia
Deep Pharma Intelligence
Delta4
DNDi
Standigm
Genesis Therapeutics
Data2Discovery
Unlearn.AI
Deep Intelligent Pharma
CarbonSilicon AI Technology
XtalPi
Tencent
Fastone
Stonewise
HitGen
Galixir
Matwings Technology
Alibaba
Segment by Type
Software Provider Mode
CRO Service Mode
Self-Development Pipeline Mode
Segment by Application
SMEs
Large Enterprises
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The AI Drug Development Platform report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Global AI Drug Development Platform market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole AI Drug Development Platform market research.
Key companies engaged in the AI Drug Development Platform industry include Insilico Medicine, MindRank, BenevolentAI, Exscientia, Deep Pharma Intelligence, Delta4, DNDi, Standigm and Genesis Therapeutics, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of AI Drug Development Platform were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole AI Drug Development Platform market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global AI Drug Development Platform market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Insilico Medicine
MindRank
BenevolentAI
Exscientia
Deep Pharma Intelligence
Delta4
DNDi
Standigm
Genesis Therapeutics
Data2Discovery
Unlearn.AI
Deep Intelligent Pharma
CarbonSilicon AI Technology
XtalPi
Tencent
Fastone
Stonewise
HitGen
Galixir
Matwings Technology
Alibaba
Segment by Type
Software Provider Mode
CRO Service Mode
Self-Development Pipeline Mode
Segment by Application
SMEs
Large Enterprises
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The AI Drug Development Platform report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI Drug Development Platform Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Software Provider Mode
1.2.3 CRO Service Mode
1.2.4 Self-Development Pipeline Mode
1.3 Market by Application
1.3.1 Global AI Drug Development Platform Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 SMEs
1.3.3 Large Enterprises
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI Drug Development Platform Market Perspective (2018-2029)
2.2 AI Drug Development Platform Growth Trends by Region
2.2.1 Global AI Drug Development Platform Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 AI Drug Development Platform Historic Market Size by Region (2018-2023)
2.2.3 AI Drug Development Platform Forecasted Market Size by Region (2024-2029)
2.3 AI Drug Development Platform Market Dynamics
2.3.1 AI Drug Development Platform Industry Trends
2.3.2 AI Drug Development Platform Market Drivers
2.3.3 AI Drug Development Platform Market Challenges
2.3.4 AI Drug Development Platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI Drug Development Platform Players by Revenue
3.1.1 Global Top AI Drug Development Platform Players by Revenue (2018-2023)
3.1.2 Global AI Drug Development Platform Revenue Market Share by Players (2018-2023)
3.2 Global AI Drug Development Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by AI Drug Development Platform Revenue
3.4 Global AI Drug Development Platform Market Concentration Ratio
3.4.1 Global AI Drug Development Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI Drug Development Platform Revenue in 2022
3.5 AI Drug Development Platform Key Players Head office and Area Served
3.6 Key Players AI Drug Development Platform Product Solution and Service
3.7 Date of Enter into AI Drug Development Platform Market
3.8 Mergers & Acquisitions, Expansion Plans
4 AI Drug Development Platform Breakdown Data by Type
4.1 Global AI Drug Development Platform Historic Market Size by Type (2018-2023)
4.2 Global AI Drug Development Platform Forecasted Market Size by Type (2024-2029)
5 AI Drug Development Platform Breakdown Data by Application
5.1 Global AI Drug Development Platform Historic Market Size by Application (2018-2023)
5.2 Global AI Drug Development Platform Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America AI Drug Development Platform Market Size (2018-2029)
6.2 North America AI Drug Development Platform Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America AI Drug Development Platform Market Size by Country (2018-2023)
6.4 North America AI Drug Development Platform Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI Drug Development Platform Market Size (2018-2029)
7.2 Europe AI Drug Development Platform Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe AI Drug Development Platform Market Size by Country (2018-2023)
7.4 Europe AI Drug Development Platform Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI Drug Development Platform Market Size (2018-2029)
8.2 Asia-Pacific AI Drug Development Platform Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific AI Drug Development Platform Market Size by Region (2018-2023)
8.4 Asia-Pacific AI Drug Development Platform Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI Drug Development Platform Market Size (2018-2029)
9.2 Latin America AI Drug Development Platform Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America AI Drug Development Platform Market Size by Country (2018-2023)
9.4 Latin America AI Drug Development Platform Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI Drug Development Platform Market Size (2018-2029)
10.2 Middle East & Africa AI Drug Development Platform Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa AI Drug Development Platform Market Size by Country (2018-2023)
10.4 Middle East & Africa AI Drug Development Platform Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Insilico Medicine
11.1.1 Insilico Medicine Company Detail
11.1.2 Insilico Medicine Business Overview
11.1.3 Insilico Medicine AI Drug Development Platform Introduction
11.1.4 Insilico Medicine Revenue in AI Drug Development Platform Business (2018-2023)
11.1.5 Insilico Medicine Recent Development
11.2 MindRank
11.2.1 MindRank Company Detail
11.2.2 MindRank Business Overview
11.2.3 MindRank AI Drug Development Platform Introduction
11.2.4 MindRank Revenue in AI Drug Development Platform Business (2018-2023)
11.2.5 MindRank Recent Development
11.3 BenevolentAI
11.3.1 BenevolentAI Company Detail
11.3.2 BenevolentAI Business Overview
11.3.3 BenevolentAI AI Drug Development Platform Introduction
11.3.4 BenevolentAI Revenue in AI Drug Development Platform Business (2018-2023)
11.3.5 BenevolentAI Recent Development
11.4 Exscientia
11.4.1 Exscientia Company Detail
11.4.2 Exscientia Business Overview
11.4.3 Exscientia AI Drug Development Platform Introduction
11.4.4 Exscientia Revenue in AI Drug Development Platform Business (2018-2023)
11.4.5 Exscientia Recent Development
11.5 Deep Pharma Intelligence
11.5.1 Deep Pharma Intelligence Company Detail
11.5.2 Deep Pharma Intelligence Business Overview
11.5.3 Deep Pharma Intelligence AI Drug Development Platform Introduction
11.5.4 Deep Pharma Intelligence Revenue in AI Drug Development Platform Business (2018-2023)
11.5.5 Deep Pharma Intelligence Recent Development
11.6 Delta4
11.6.1 Delta4 Company Detail
11.6.2 Delta4 Business Overview
11.6.3 Delta4 AI Drug Development Platform Introduction
11.6.4 Delta4 Revenue in AI Drug Development Platform Business (2018-2023)
11.6.5 Delta4 Recent Development
11.7 DNDi
11.7.1 DNDi Company Detail
11.7.2 DNDi Business Overview
11.7.3 DNDi AI Drug Development Platform Introduction
11.7.4 DNDi Revenue in AI Drug Development Platform Business (2018-2023)
11.7.5 DNDi Recent Development
11.8 Standigm
11.8.1 Standigm Company Detail
11.8.2 Standigm Business Overview
11.8.3 Standigm AI Drug Development Platform Introduction
11.8.4 Standigm Revenue in AI Drug Development Platform Business (2018-2023)
11.8.5 Standigm Recent Development
11.9 Genesis Therapeutics
11.9.1 Genesis Therapeutics Company Detail
11.9.2 Genesis Therapeutics Business Overview
11.9.3 Genesis Therapeutics AI Drug Development Platform Introduction
11.9.4 Genesis Therapeutics Revenue in AI Drug Development Platform Business (2018-2023)
11.9.5 Genesis Therapeutics Recent Development
11.10 Data2Discovery
11.10.1 Data2Discovery Company Detail
11.10.2 Data2Discovery Business Overview
11.10.3 Data2Discovery AI Drug Development Platform Introduction
11.10.4 Data2Discovery Revenue in AI Drug Development Platform Business (2018-2023)
11.10.5 Data2Discovery Recent Development
11.11 Unlearn.AI
11.11.1 Unlearn.AI Company Detail
11.11.2 Unlearn.AI Business Overview
11.11.3 Unlearn.AI AI Drug Development Platform Introduction
11.11.4 Unlearn.AI Revenue in AI Drug Development Platform Business (2018-2023)
11.11.5 Unlearn.AI Recent Development
11.12 Deep Intelligent Pharma
11.12.1 Deep Intelligent Pharma Company Detail
11.12.2 Deep Intelligent Pharma Business Overview
11.12.3 Deep Intelligent Pharma AI Drug Development Platform Introduction
11.12.4 Deep Intelligent Pharma Revenue in AI Drug Development Platform Business (2018-2023)
11.12.5 Deep Intelligent Pharma Recent Development
11.13 CarbonSilicon AI Technology
11.13.1 CarbonSilicon AI Technology Company Detail
11.13.2 CarbonSilicon AI Technology Business Overview
11.13.3 CarbonSilicon AI Technology AI Drug Development Platform Introduction
11.13.4 CarbonSilicon AI Technology Revenue in AI Drug Development Platform Business (2018-2023)
11.13.5 CarbonSilicon AI Technology Recent Development
11.14 XtalPi
11.14.1 XtalPi Company Detail
11.14.2 XtalPi Business Overview
11.14.3 XtalPi AI Drug Development Platform Introduction
11.14.4 XtalPi Revenue in AI Drug Development Platform Business (2018-2023)
11.14.5 XtalPi Recent Development
11.15 Tencent
11.15.1 Tencent Company Detail
11.15.2 Tencent Business Overview
11.15.3 Tencent AI Drug Development Platform Introduction
11.15.4 Tencent Revenue in AI Drug Development Platform Business (2018-2023)
11.15.5 Tencent Recent Development
11.16 Fastone
11.16.1 Fastone Company Detail
11.16.2 Fastone Business Overview
11.16.3 Fastone AI Drug Development Platform Introduction
11.16.4 Fastone Revenue in AI Drug Development Platform Business (2018-2023)
11.16.5 Fastone Recent Development
11.17 Stonewise
11.17.1 Stonewise Company Detail
11.17.2 Stonewise Business Overview
11.17.3 Stonewise AI Drug Development Platform Introduction
11.17.4 Stonewise Revenue in AI Drug Development Platform Business (2018-2023)
11.17.5 Stonewise Recent Development
11.18 HitGen
11.18.1 HitGen Company Detail
11.18.2 HitGen Business Overview
11.18.3 HitGen AI Drug Development Platform Introduction
11.18.4 HitGen Revenue in AI Drug Development Platform Business (2018-2023)
11.18.5 HitGen Recent Development
11.19 Galixir
11.19.1 Galixir Company Detail
11.19.2 Galixir Business Overview
11.19.3 Galixir AI Drug Development Platform Introduction
11.19.4 Galixir Revenue in AI Drug Development Platform Business (2018-2023)
11.19.5 Galixir Recent Development
11.20 Matwings Technology
11.20.1 Matwings Technology Company Detail
11.20.2 Matwings Technology Business Overview
11.20.3 Matwings Technology AI Drug Development Platform Introduction
11.20.4 Matwings Technology Revenue in AI Drug Development Platform Business (2018-2023)
11.20.5 Matwings Technology Recent Development
11.21 Alibaba
11.21.1 Alibaba Company Detail
11.21.2 Alibaba Business Overview
11.21.3 Alibaba AI Drug Development Platform Introduction
11.21.4 Alibaba Revenue in AI Drug Development Platform Business (2018-2023)
11.21.5 Alibaba Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
